<DOC>
	<DOCNO>NCT00120146</DOCNO>
	<brief_summary>This trial test hypothesis among obese adolescent , treatment extended-release metformin ( GlucophageÂ® XR ) , couple lifestyle intervention , result decrease obesity ( measure body mass index [ BMI ] ) compare subject receive treatment placebo lifestyle intervention .</brief_summary>
	<brief_title>Metformin Obesity Study</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Subjects must age 13.00 17.99 week 0 ( Baseline ) Subjects must BMI &gt; 95th percentile age gender use CDC data , must weigh less 300 pound ( &lt; 136 kilogram ) week 0 ( Baseline ) Completion inform consent/assent process Subjects exclude study following : Known diabetes define American Diabetes Association criterion . Prior drug therapy treat diabetes insulin insensitivity Has ever use medication aid weight loss Subject currently take follow medication time Screening visit : cimetidine , amiloride , digoxin , furosemide , morphine , nifedipine , procainamide , ranitidine , triamterene , trimethoprim , vancomycin quinidine , medication may increase metformin level . Recent glucocorticoid therapy History syndrome medical disorder associate significant obesity Recent history involvement formal weight loss program Alcohol use Elevated creatinine ( &gt; 1.2 mg/dl ) Untreated disorder thyroid function Elevated liver enzymes ( Alanine Aminotransferase [ ALT ] Aspartate Aminotransferase [ AST ] ) &gt; 80 ( approximately 2 time upper limit normal ) . An AST ALT &gt; 2 time upper limit normal chosen base data show approximately 5 % obese adolescent liver enzymes great 2 time upper limit normal clinical setting . Mobility impairment prevents full participation recommend physical activity Other serious medical condition Principal Investigator Lead Site Investigator determines may put patient undue risk enrol study Unable comply protocol opinion Principal Investigator Lead Site Investigator Subjects childbearing potential unwilling remain abstinent use effective method birth control . Females least one menstrual cycle must either abstinent must consistently use effective method birth control ( e.g. , intrauterine contraceptive device , oral contraceptive medroxyprogesterone acetate barrier method [ diaphragm condom ] plus contraceptive jelly , cream , foam ) study . This documented visit . Additionally , female begin menstruate must negative result urine pregnancy test administer every visit order remain study drug undergo radiologic procedure . Previous pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>